Serafin Labs, Inc. — Form D
Serafin Labs, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-14. The offering totals $1.0M, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-14
- Form: D
- Accession: 0002104899-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $50K
- Remaining: $950K
- Investors: 2
- Date of first sale: 2025-12-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-569814
Issuer
- Name: Serafin Labs, Inc.
- CIK: 0002104899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 3971 LAMONT STREET, SAN DIEGO, CA, 92109
- Phone: 3019380436
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Stephanie Fraley | Director | San Diego, CA |
| Daya Ranamukhaarachchi | Director | San Diego, CA |
| Sural Ranamukhaarachchi | Director | San Diego, CA |
| Sural Ranamukhaarachchi | Executive Officer | San Diego, CA |
| Sural Ranamukhaarachchi | Promoter | San Diego, CA |
More